Related Experiment Video
Updated: Jun 13, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Serum lysozyme in inflammatory bowel disease.
Gastroenterology
|June 1, 1976
Summary
Serum lysozyme (muramidase) levels were higher in Crohn's disease patients compared to controls. However, significant overlap in levels between Crohn's disease and ulcerative colitis patients suggests further research is needed.
Area of Science:
- Biochemistry
- Gastroenterology
- Immunology
Background:
- Lysozyme (muramidase) is an enzyme involved in innate immunity.
- Altered immune responses are implicated in inflammatory bowel diseases (IBD).
- Serum lysozyme levels may serve as a biomarker in IBD.
Purpose of the Study:
- To investigate serum lysozyme concentrations in patients with ulcerative colitis (UC) and Crohn's disease (CD).
- To compare lysozyme levels between IBD patient groups and healthy controls.
- To assess the potential of lysozyme as a diagnostic marker for differentiating IBD subtypes.
Main Methods:
- Serum samples were collected from three groups: healthy controls, patients with ulcerative colitis and proctitis, and patients with Crohn's disease.
- Lysozyme concentrations were quantified using a standard assay.
- Statistical analysis was performed to compare mean lysozyme levels across groups.
Main Results:
- Mean serum lysozyme concentration in controls was 7 +/- 2 U/mL.
- Mean serum lysozyme concentration in ulcerative colitis and proctitis patients was 7 +/- 2 U/mL.
- Mean serum lysozyme concentration in Crohn's disease patients was 10 +/- 4 U/mL.
- A statistically significant difference was observed between Crohn's disease patients and both control and ulcerative colitis patients.
- A notable overlap in serum lysozyme concentrations was found between Crohn's disease and ulcerative colitis groups.
Conclusions:
- Serum lysozyme levels are elevated in Crohn's disease compared to ulcerative colitis and controls.
- The overlap in lysozyme levels limits its utility as a sole diagnostic marker for differentiating Crohn's disease from ulcerative colitis.
- Further research is warranted to elucidate the role of lysozyme in IBD pathogenesis and to reconcile findings with previous studies.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...